Estimating the incidence, prevalence and clinical burden of hepatitis C over time in Italy

References

• The Global Burden of Hepatitis C Working Group. Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol 2004;44:20–9.
   PubMed Web of Science ®Google Scholar
• Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005; 5: 558–67
   PubMed Web of Science ®Google Scholar
• CDC – Centers for Disease Control and Prevention. Hepatitis Surveillance, Report No. 60. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, 2005.
   Google Scholar
• Mele, A, Tosti, ME, Spada, E, Mariano, A, Bianco, E, SEIEVA Collaborative Group. Epidemiology of acute viral hepatitis: 20 y of surveillance through SEIEVA in Italy and a review of the literature. Rapporti ISTISAN 2006/12. Available at, , www.iss.it.
   Google Scholar
• Deuffic S, Buffat L, Poynard T, Valleron AJ. Modelling the hepatitis C virus epidemic in France. Hepatology 1999; 29: 1596–1601
   PubMed Web of Science ®Google Scholar
• Armstrong GL, Alter MJ, McQuillan GM, Margolis HS. The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States. Hepatology 2000; 31: 777–82
   PubMed Web of Science ®Google Scholar
• Zou S, Tepper M, El Saadany S. Prediction of hepatitis C burden in Canada. Can J Gastroenterol 2000; 14: 575–80
   PubMed Web of Science ®Google Scholar
• Buti M, San Miguel R, Brosa M, Cabasés JM, Medina M, Angel Casado M, et al. Estimating the impact of hepatitis C virus therapy on future liver related morbidity, mortality and costs related to chronic hepatitis C. J Hepatol 2005; 42: 639–45
   PubMed Web of Science ®Google Scholar
• Hutchinson SJ, Bird SM, Goldberg DJ. Modelling the current and future disease burden of hepatitis C among injection drug users in Scotland. Hepatology 2005; 42: 711–23
   PubMed Web of Science ®Google Scholar
• Sagnelli E, Stroffolini T, Mele A, Almasio P, Coppola N, Ferrigno L, et al. The importance of HCV on the burden of chronic liver disease in Italy: a multicentre prevalence study of 9997 cases. J Med Virol 2005; 75: 522–7
   PubMed Web of Science ®Google Scholar
• Fagiuoli S, Mirante VG, Pompili M, Gianni S, Leandro G, Rapaccini GL, et al. Liver transplantation: the Italian experience. Digest Liver Dis 2002; 34: 640–8
   Web of Science ®Google Scholar
• Stroffolini T, D'Argenio P, Mele A. Prevalence of hepatitis C virus infection in the United States. N Engl J Med 1999; 341: 2094
   PubMed Web of Science ®Google Scholar
• Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144: 705–14
   PubMed Web of Science ®Google Scholar
• ISTAT – National Statistics Institute of Italy. Population census, interpolated and extrapolated population tables. Available at, , www.demo.istat.it. Last accessed on the 15th of December, 2008.
   Google Scholar
• Mathei C, Buntinx F, van Damme P. Seroprevalence of hepatitis C markers among intravenous drug users in Western European countries: a systematic review. J Viral Hepat 2002; 9: 157–73
   PubMed Web of Science ®Google Scholar
• Roy K, Hay G, Andragetti R, Taylor A, Goldberg D, Wiessing L. Monitoring hepatitis C virus infection among injecting drug users in the European Union: a review of the literature. Epidemiol Infect 2002; 129: 577–85
   PubMed Web of Science ®Google Scholar
• Rossi C. Estimating the prevalence of injecting drug users on the basis of Markov models of the HIV/AIDS epidemic: applications to Italian data. Health Care Manag Sci 1999; 2: 173–9
   PubMedGoogle Scholar
• Reitox National Focal Point. Italy, 2005 national report to the EMCDDA. Available at, , www.emcdda.eu.int. Last accessed on the 15th of December, 2008.
   Google Scholar
• Bortolotti F, Crivellaro C, Carretta M, Tagger A, Ribero M, Bertolini A, et al. Acute non-A, non-B hepatitis in Italy: a 16-y prospective epidemiological study. The possible role of hepatitis C virus. Infection 1994; 22: 321–5
   PubMed Web of Science ®Google Scholar
• Giusti G, Ruggiero G, Galanti B, Piccinino F, Sagnelli E, Lucchelli PE. Acute viral hepatitis in Italy, results of a collaborative study. Acta Hepato-Gastroenterol 1977; 24: 226–37
   PubMedGoogle Scholar
• Mele A, Rosmini F, Zampieri A, Gill ON. Integrated epidemiological system for acute viral hepatitis in Italy (SEIEVA): description and preliminary results. Eur J Epidemiol 1986; 2: 300–4
   PubMedGoogle Scholar
• Kondili LA, Chionne P, Costantino A, Villano U, Lo Noce C, Pannozzo F, et al. Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural course of hepatitis C virus infection in the general population. Gut 2002; 50: 693–6
   PubMed Web of Science ®Google Scholar
• ISTAT – National Statistics Institute of Italy. Mortality database. Available at, , www.iss.it/site/mortalita/. Last accessed on the 15th of December, 2008.
   Google Scholar
• Esteban JI, Sauleda S, Quer J. The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol 2008; 48: 148–62
   PubMed Web of Science ®Google Scholar
• Massard J, Ratziu V, Thabut D, Moussalli J, Lebray P, Benhamou Y, et al. Natural history and predictors of disease severity in chronic hepatitis C. J Hepatol 2006; 44: S19–24
   PubMed Web of Science ®Google Scholar
• Freeman AJ, Law MG, Kaldor JM, Dore GJ. Predicting progression to cirrhosis in chronic hepatitis C virus infection. J Viral Hepat 2003; 10: 285–93
   PubMed Web of Science ®Google Scholar
• Fattovich G, Giustina G, Degos F, Tremolada F, Diodati G, Almasio P, et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 1997; 112: 463–72
   PubMed Web of Science ®Google Scholar
• Gentilini P, Laffi G, La Villa G, Romanelli RG, Buzzelli G, Casini-Raggi V, et al. Long-course and prognostic factors of virus induced cirrhosis of the liver. Am J Gastroenterol 1997; 92: 66–72
   PubMed Web of Science ®Google Scholar
• Serfaty L, Aumaitre H, Chazouilleres O, Bonnand AM, Rosmorduc O, Poupon RE, et al. Determinants of outcome of compensated hepatitis C virus related cirrhosis. Hepatology 1998; 27: 1435–40
   PubMed Web of Science ®Google Scholar
• Hu KQ, Tong MJ. The long-term outcomes of patients with compensated hepatitis C-related cirrhosis and history of parenteral exposure in the United States. Hepatology 1999; 29: 1311–6
   PubMed Web of Science ®Google Scholar
• Degos F, Christidis C, Ganne-Carrie N, Farmachidi JP, Degott C, Guettier C, et al. Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death. Gut 2000; 47: 131–6
   PubMed Web of Science ®Google Scholar
• Fattovich, G, Pantalena, M, Zagni, I, Realdi, G, Schalm, SW, Christensen, E, European Concerted Action on Viral Hepatitis (EUROHEP). Effect of hepatitis B and hepatitis C infections on the natural history of compensated cirrhosis: a cohort study of 297 patients. Am J Gastroenterol 2002;97:2886–95.
   PubMed Web of Science ®Google Scholar
• Benvegnù L, Gios M, Boccato S, Alberti A. Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications. Gut 2004; 53: 744–9
   PubMed Web of Science ®Google Scholar
• Sangiovanni A, Prati GM, Fasani P, Ronchi G, Romeo R, Manini M, et al. The natural history of compensated cirrhosis due to hepatitis C virus: a 17-y cohort study of 214 patients. Hepatology 2006; 43: 1303–10
   PubMed Web of Science ®Google Scholar
• D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006; 44: 217–31
   PubMed Web of Science ®Google Scholar
• Gessoni G, Manoni F. Prevalence of anti-hepatitis C virus antibodies among teenagers in the Venetian area: a seroepidemiological study. Eur J Med 1993; 2: 79–82
   PubMedGoogle Scholar
• Patti AM, Bellucci C, Bagnod S, Pompa MG, Santi AL, Giustini C, et al. A serological study of the spread of hepatitis C infection in 14-y-old residents of the Lazio region. Ann Ig 1994; 6: 637–40
   PubMedGoogle Scholar
• Romanò L, Azara A, Chiaramonte M, de Mattia D, Giammanco A, Moschen ME, et al. Low prevalence of anti-HCV antibody among Italian children. Infection 1994; 22: 350–2
   PubMed Web of Science ®Google Scholar
• Marranconi F, Fabris P, Stecca C, Zampieri L, Bettini MC, di Fabrizio N, et al. Prevalence of anti-HCV and risk factors for hepatitis C virus infection in healthy pregnant women. Infection 1994; 22: 333–7
   PubMed Web of Science ®Google Scholar
• Floreani A, Paternoster D, Zappala F, Cusinato R, Bombi G, Grella P, et al. Hepatitis C virus infection in pregnancy. Br J Obstet Gynaecol 1996; 103: 325–9
   PubMedGoogle Scholar
• Molesini M, Cinquetti M, Dolci L, Barlocco EG, Marchi D, Vinco A, et al. Prevalence of HCV antibodies and vertical transmission of hepatitis C virus. Pediatr Med Chir 1996; 18: 43–5
   PubMedGoogle Scholar
• Sabatino G, Ramenghi LA, di Marzio M, Pizzigallo E. Vertical transmission of hepatitis C virus: an epidemiological study on 2980 pregnant women in Italy. Eur J Epidemiol 1996; 12: 443–7
   PubMed Web of Science ®Google Scholar
• Baldo V, Floreani A, Menegon T, Grella P, Paternoster DM, Trivello R. Hepatitis C virus, hepatitis B virus and human immunodeficiency virus infection in pregnant women in north-east Italy: a seroepidemiological study. Eur J Epidemiol 2000; 16: 87–91
   PubMed Web of Science ®Google Scholar
• Conte D, Fraquelli M, Prati D, Colucci A, Minola E. Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women. Hepatology 2000; 31: 751–5
   PubMed Web of Science ®Google Scholar
• Ferrero S, Lungaro P, Bruzzone BM, Gotta C, Bentivoglio G, Ragni N. Prospective study of mother-to-infant transmission of hepatitis C virus: a 10-y survey (1990–2003). Acta Obstet Gynecol Scand 2003; 82: 229–34
   PubMed Web of Science ®Google Scholar
• Stroffolini T, Menchinelli M, Taliani G, Dambruoso V, Poliandri G, Bozza A, et al. High prevalence of hepatitis C virus infection in a small central Italian town: lack of evidence of parenteral exposure. Ital J Gastroenterol 1995; 27: 235–8
   PubMedGoogle Scholar
• Guadagnino V, Stroffolini T, Rapicetta M, Costantino A, Kondili LA, Menniti-Ippolito F, et al. Prevalence, risk factors and genotype distribution of hepatitis C virus infection in the general population: a community based survey in southern Italy. Hepatology 1997; 26: 1006–11
   PubMed Web of Science ®Google Scholar
• Osella AR, Misciagna G, Leone A, di Leo A, Fiore G. Epidemiology of hepatitis C virus infection in an area of southern Italy. J Hepatol 1997; 27: 30–5
   PubMed Web of Science ®Google Scholar
• Monica F, Lirussi F, Nassuato G, Castelletto MR, Mottola A, Okolicsanyi L. Hepatitis C virus infection and related chronic liver disease in a resident elderly population: the Silea Study. J Viral Hepat 1998; 5: 345–51
   PubMed Web of Science ®Google Scholar
• Bellentani S, Pozzato G, Saccoccio G, Crovatto M, Crocè LS, Mazzoran L, et al. Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos Study. Gut 1999; 44: 874–80
   PubMed Web of Science ®Google Scholar
• Loviselli A, Oppo A, Velluzzi F, Atzeni F, Mastinu GL, Farci P, et al. Independent expression of serological markers of thyroid autoimmunity and hepatitis virus C infection in the general population: results of a community based study in north-western Sardinia. J Endocrinol Invest 1999; 22: 660–5
   PubMed Web of Science ®Google Scholar
• Maggi G, Armitano S, Brambilla L, Brenna M, Cairo M, Galvani G, et al. Hepatitis C infection in an Italian population not selected for risk factors. Liver 1999; 19: 427–31
   PubMedGoogle Scholar
• Baldo V, Floreani A, Menegon T, Angiolelli G, Trivello R. Prevalence of antibodies against hepatitis C virus in the elderly: a seroepidemiological study in a nursing home and in an open population. The Collaborative Group. Gerontology 2000; 46: 194–8
   PubMed Web of Science ®Google Scholar
• Maio G, D'Argenio P, Stroffolini T, Bozza A, Sacco L, Tosti ME, et al. Hepatitis C virus infection and alanine transaminase levels in the general population: a survey in a southern Italian town. J Hepatol 2000; 33: 116–20
   PubMed Web of Science ®Google Scholar
• Raffaele A, Valenti M, Iovenitti M, Matani A, Bruno ML, Altobelli E, et al. High prevalence of HCV infection among the general population in a rural area of central Italy. Eur J Epidemiol 2001; 17: 41–6
   PubMed Web of Science ®Google Scholar
• di Stefano R, Stroffolini T, Ferraro D, Usticano A, Valenza LM, Montalbano L, et al. Endemic hepatitis C virus infection in a Sicilian town: further evidence for iatrogenic trasmission. J Med Virol 2002; 67: 339–44
   PubMed Web of Science ®Google Scholar
• Mazzeo C, Azzaroli F, Giovanelli S, Dormi A, Festi D, Colecchia A, et al. 10-y incidence of HCV infection in northern Italy and frequency of spontaneous viral clearance. Gut 2003; 52: 1030–4
   PubMed Web of Science ®Google Scholar
• Pendino GM, Mariano A, Surace P, Caserta CA, Fiorillo MT, Amante A, et al. Prevalence and aetiology of altered liver tests: a population based survey in a Mediterranean town. Hepatology 2005; 41: 1151–9
   PubMed Web of Science ®Google Scholar
• Quaglio GL, Lugoboni F, Pajusco B, Sarti M, Talamini G, Mezzelani P, et al. Hepatitis C virus infection: prevalence, predictor variables and prevention opportunities among drug users in Italy. J Viral Hepat 2003; 10: 394–400
   PubMed Web of Science ®Google Scholar
• Babudieri S, Longo B, Sarmati L, Starnini G, Dori L, Suligoi B, et al. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy. J Med Virol 2005; 76: 311–7
   PubMed Web of Science ®Google Scholar
• Montella M, Crispo A, Grimaldi M, Angeletti C, Amore A, Ronga D, et al. Prevalence of hepatitis C virus infection in different populations groups in southern Italy. Infection 2005; 33: 9–12
   PubMed Web of Science ®Google Scholar
• Strader, DB, Wright, T, Thomas, DL, Seeff, LB, American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C. Hepatology 2004;39:1147–71.
   PubMed Web of Science ®Google Scholar
• Angelico, M, Gridelli, B, Strazzabosco, M, A.I.S.F. Commission on Liver Transplantation. Practice of adult liver transplantation in Italy. Recommendations of the Italian Association for the Study of the Liver (A.I.S.F.). Dig Liver Dis 2005;37:461–7.
   PubMedGoogle Scholar
• Mariano, A, Caserta, C, Pendino, GM, Vacalebre, C, Surace, P, Fiorillo, MT, et al. Antiviral treatment for hepatitis C virus infection: effectiveness at general population level in a highly endemic area. Dig Liver Dis 2009, Feb 2. (Epub ahead of print)
   PubMedGoogle Scholar
• Ferenci P, Ferenci S, Datz C, Rezman I, Oberaigner W, Strauss R. Morbidity and mortality in paid Austrian plasma donors infected with hepatitis C at plasma donation in the 1970s. J Hepatol 2007; 47: 31–6
   PubMed Web of Science ®Google Scholar
• Wong JB, McQuillan GM, McHutchison JG, Poynard T. Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health 2000; 90: 1562–9
   PubMed Web of Science ®Google Scholar
• Salomon JA, Weinstein MC, Hammitt JK, Goldie SJ. Empirically calibrated model of hepatitis C virus infection in the United States. Am J Epidemiol 2002; 156: 761–3
   PubMed Web of Science ®Google Scholar
• Ansaldi F, Bruzzone B, Salmaso S, Rota MC, Durando P, Gasparini R, et al. Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy. J Med Virol 2005; 76: 327–32
   PubMed Web of Science ®Google Scholar
• Ferraro D, Genovese D, Argentini C, Giordano V, Pizzillo P, Stroffolini T, et al. Phylogenetic reconstruction of HCV genotype 1b dissemination in a small city centre: the Camporeale model. J Med Virol 2008; 80: 1723–31
   PubMed Web of Science ®Google Scholar
• Chiaramonte M, Stroffolini T, Lorenzoni U, Minniti F, Conti S, Floreani A, et al. Risk factors in community acquired chronic hepatitis C virus infection: a case-control study in Italy. J Hepatol 1996; 24: 129–34
   PubMed Web of Science ®Google Scholar
• The Writing Committee on behalf of the Consensus Panel. Expert Consensus Conference: the screening for hepatitis C virus infection in adults in Italy, May 5–6, 2005. Digestive and Liver Disease 2006;38:445–51.
   Web of Science ®Google Scholar